Guardion Announces Virtual Annual Meeting of Stockholders
11 sept. 2020 17h20 HE
|
Guardion Health Sciences, Inc.
Annual stockholder meeting scheduled for Thursday, October 29, 2020 San Diego, California, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc.(“Guardion” or the...
Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark
15 juil. 2020 09h00 HE
|
Guardion Health Sciences, Inc.
The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests San Diego, California, July 15, 2020 (GLOBE NEWSWIRE) --...
Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease
08 juil. 2020 08h45 HE
|
Guardion Health Sciences, Inc.
Patent Application Will Add to Guardion’s Intellectual Property Portfolio San Diego, California, July 08, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
Guardion Health Sciences Names Dr. David Evans as Interim President and Interim Chief Executive Officer
15 juin 2020 16h20 HE
|
Guardion Health Sciences, Inc.
San Diego, California, June 15, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced today that its Board of Directors has appointed Dr....
Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
14 mai 2020 07h00 HE
|
Guardion Health Sciences, Inc.
— 40% increase in medical foods revenue in the first quarter compared to the same period last year — Launch of immuno-supportive/antioxidant complex, acuMMUNE™ — Growing portfolio of synergistic...
Lumega-Z® Demonstrates Superiority in a Head-to-Head Study Showing Better Bioavailability of Carotenoids and Restoring Macular Pigment Density
12 mai 2020 07h05 HE
|
Guardion Health Sciences, Inc.
-- First study to provide a head-to-head comparison of two commercially available supplements with regard to the changes in serum levels of carotenoids, visual function and macular pigment optical...
Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit
15 avr. 2020 09h05 HE
|
Guardion Health Sciences, Inc.
– Presentation with live audio webcast on Wednesday, April 22 at 1:30 PM ET, immediately followed by an interactive Q&A session – San Diego, California, April 15, 2020 (GLOBE NEWSWIRE)...
Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants
06 mars 2020 08h05 HE
|
Guardion Health Sciences, Inc.
San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates,...
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
07 janv. 2020 11h02 HE
|
Guardion Health Sciences, Inc.
San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019
14 nov. 2019 07h00 HE
|
Guardion Health Sciences, Inc.
Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...